Legacy App users can now access the Health Portal – just reset your password using email as username.

Getting Fertile on Testosterone & Steroids – Doctor’s Discussion

Getting Fertile on Testosterone & Steroids – Doctor’s Discussion

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
An introduction frames fertility on testosterone or anabolic steroids as a predictable outcome for a subset of men. The clinician previews physiology, medication strategies, and the importance of semen analysis for planning.
01:15
Even small androgen exposure is described as capable of shutting down gonadotropin output from the brain. The presenter explains that LH and FSH are the critical signals that normally stimulate the testes.
02:30
Fertility preservation is described as easier when planning happens before starting hormones. The clinician recommends semen analysis and sperm storage up front, because recovery difficulty varies across the spectrum.
03:48
Low-dose HCG paired with testosterone is presented as a possible way to maintain more normal semen function early for some men. The clinician warns that benefits can fade over time, especially when dosing is inconsistent.
05:05
Coming off steroids and testosterone is described as one common pathway, with sperm counts potentially improving over two to three months in younger men. Post-cycle strategies are reviewed using HCG with tamoxifen or Clomid, plus discussion of aromatase inhibitors.
06:20
Higher-intensity protocols are discussed using 1500 to 3000 units of HCG every other day, sometimes combined with Clomid dosing. The clinician notes that fertility specialists may use expensive LH and FSH analogs and pursue IVF-related procedures when needed.
07:36
Long-term concurrent HCG use is discouraged because estrogen may rise and the injection burden becomes difficult to sustain. A practical alternative described is smaller HCG doses with testosterone or stopping androgens and starting fertility-focused medications.
08:52
When conception does not happen after ninety days, repeating semen analysis is framed as essential for guiding next decisions. The clinician mentions an at-home sperm testing and storage service called Legacy while emphasizing that outcomes should be tracked with real data.

Video Summary

The clinician addresses men who want a child while using testosterone or other anabolic steroids, because suppression is predictable for some users. The presenter explains that reproductive endocrinology on androgens follows clear physiology, even when symptoms feel confusing. The discussion begins with how the hypothalamus and pituitary normally send gonadotropin signals to the testes. Once exogenous androgens are introduced, those signals drop, and fertility issues can develop without obvious warning. The presenter notes that the spectrum ranges from TRT-level dosing to full anabolic dosing, and suppression can occur anywhere along it. Age, duration, and cycling history are described as important factors that influence how difficult recovery becomes. A core recommendation is to obtain a semen analysis and store sperm before starting hormones, especially when future family plans are uncertain.

Mechanistically, the clinician states that LH and FSH drive Leydig and Sertoli cell activity, supporting testosterone production and semen formation. When testosterone or steroid exposure provides strong negative feedback, gonadotropins fall and the testes can become atrophied over time. For some men, small doses of HCG taken with testosterone can temporarily maintain more normal semen function early in the process. However, the clinician describes seeing men lose that benefit after months or years, especially when dosing is inconsistent or intermittently skipped. Another pathway described is coming off androgens for several weeks and then fully stopping, allowing sperm counts to rebound over two to three months. Blasting and cruising is portrayed as harder, because coming off often feels miserable and drives men back toward quick fixes. Post-cycle approaches are reviewed, including HCG with tamoxifen or Clomid, and aromatase inhibitors that only block estrogen rather than restoring fertility alone.

For more difficult cases, the clinician describes higher-dose fertility protocols such as 1500 to 3000 units of HCG every other day, sometimes paired with Clomid. The presenter adds that fertility specialists may use expensive LH and FSH analogs, including recombinant products, and they may pursue IVF-related procedures. Using HCG concurrently with testosterone is discouraged for long stretches, because estrogen can rise and the injection burden becomes hard to sustain. If someone stays on testosterone while trying to preserve fertility, the clinician suggests smaller HCG doses like 250 to 400 two or three times weekly. When a couple is trying and nothing happens after ninety days, repeating semen analysis is framed as essential, because the data guides next steps. A case example includes a partner using an ovulation kit while the man follows HCG plus Clomid, yet conception still fails after months. The closing message is to avoid being willy-nilly, use a fertility urologist when needed, and make decisions based on measurable signals rather than hope.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an exogenous androgen that can suppress pituitary LH and FSH output through negative feedback. The clinician explains that suppression can reduce semen and sperm production even at TRT-style dosing for some men.
HCG
HCG is described as an LH-like gonadotropin used to stimulate testicular signaling in fertility-focused plans. The presenter contrasts small maintenance dosing with higher dosing used after stopping testosterone and steroids.
Clomid
Clomid is discussed as a selective estrogen receptor modulator used to stimulate pituitary output of gonadotropins. The clinician describes pairing Clomid with HCG in post-cycle or fertility-support strategies when appropriate.
Tamoxifen
Tamoxifen is mentioned as a SERM option that can be part of post-cycle planning and is also described as blocking gynecomastia effects. The clinician includes it among tools used when men come off steroids and want to restore fertility signals.
Aromatase inhibitors
Aromatase inhibitors are referenced as drugs that block conversion pathways leading to estrogen formation. The clinician notes that these agents only block estrogen and do not automatically restore fertility without broader axis support.
Recombinant LH/FSH analogs
Recombinant LH and FSH analogs are described as expensive fertility medicines used by specialist practices. The presenter links these analogs to higher-complexity cases that may also involve IVF and other procedures.

Condition Callouts

Condition
Description
Infertility
Infertility is difficulty achieving pregnancy that can arise when sperm production declines under androgen suppression. The clinician frames infertility as predictable in a subset of men using testosterone or anabolic steroids.
Testicular atrophy
Testicular atrophy is reduced testicular size or function that can follow prolonged suppression of reproductive signaling. The clinician explicitly states that atrophied testes change recovery difficulty and may require structured stimulation strategies.
Suppressed LH and FSH
Suppressed LH and FSH refers to reduced gonadotropin output from the brain, which normally stimulates the testes. The presenter explains that even small androgen exposure can shut down these signals and impair semen production.
Gynecomastia
Gynecomastia is breast gland tissue growth or tenderness driven by estrogen signaling. The clinician mentions tamoxifen as a receptor-blocking option that can blunt gynecomastia effects in some scenarios.
Elevated estrogen
Elevated estrogen is described as a possible consequence when HCG is used concurrently and aromatization increases. The clinician warns that rising estrogen plus injection burden makes long-term concurrent HCG use hard for many men.
Low testosterone symptoms
Low testosterone symptoms are described as a common reason men struggle when coming off testosterone or steroids. The clinician notes that feeling unwell can push men back toward quick fixes instead of completing fertility recovery plans.

Key Takeaways

  • Testosterone and anabolic steroids are described as capable of suppressing LH and FSH, which reduces semen and sperm production for some men.
  • Semen analysis and sperm storage before starting hormones are presented as the most protective fertility planning steps.
  • Small HCG doses with testosterone may help maintain semen function early, yet benefits can fade with time or inconsistent dosing.
  • Coming off hormones for weeks and then fully stopping can allow sperm counts to rebound over two to three months in younger men.
  • Higher-dose HCG with Clomid and specialist options like recombinant gonadotropins or IVF procedures are discussed for more difficult cases.